𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Serum carnitine levels and levocarnitine supplementation in institutionalized Huntington’s disease patients

✍ Scribed by Miroslav Cuturic, Ruth K. Abramson, Robert R. Moran, James W. Hardin, Elaine M. Frank, Andrea A. Sellers

Book ID
118270757
Publisher
Springer Milan
Year
2012
Tongue
English
Weight
194 KB
Volume
34
Category
Article
ISSN
1590-1874

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Low brain-derived neurotrophic factor (B
Low brain-derived neurotrophic factor (BDNF) levels in serum of Huntington's disease patients
✍ A. Ciammola; J. Sassone; M. Cannella; S. Calza; B. Poletti; L. Frati; F. Squitie 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 67 KB 👁 2 views

## Abstract Huntington's disease (HD) is a neurodegenerative disorder characterized by motor, cognitive, and psychiatric symptoms and by a progressive degeneration of neurons in basal ganglia and in brain cortex. Brain‐derived neurotrophic factor (BDNF) is a pro‐survival factor for striatal neurons